Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Cervical Dysplasia Market to Grow at 7.2% CAGR through 2024, North America to Hold Largest Revenue Share

Press release Description

Albany, New York, July 11, 2018: A new insightful study titled “Cervical Dysplasia Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2024” has recently been submitted to the database of Market Research Reports Search Engine (MRRSE). The report examines historical trends of the global cervical dysplasia market and shares market forecast from 2017 to 2024.

According to the report, the global cervical dysplasia market which was evaluated for US$394.0 million during 2017, is expected to be valued for US$640.2 million by the end of 2024. The report further projects that the global cervical dysplasia market is estimated to grow at a CAGR of 7.2% during the assessment period 2017 – 2024.

The report segments the global cervical dysplasia market on the basis of end-user, diagnosis and region. The end-user segment is further divided into diagnostic centers, private gynecologist’s offices, hospitals, research & academic institutes and ambulatory surgical centers. The diagnosis segment is bifurcated into diagnostic test and diagnostic device. The diagnostic test is divided into HPV test, biopsy and pap smear test. The diagnostic device has been analyzed on the basis of colposcopy category. According to the report, the diagnostic tests segment held nearly 86.3% of the market share during 2015. The report also projects that the HPV tests has been estimated to grow at a higher CAGR during the forecast period due to the advancement in technology and also increasing aversion to pap smear test for high cost.

Geographically, the market is divided into key regions globally which are North America, Latin America, Europe, Asia Pacific and Middle East & Africa. As per the report, North America region held market share of 54.8% during 2017 for cervical dysplasia market globally. As per the report, due to the availability of reimbursement screening tests in markets such as North America and Europe, the global cervical dysplasia market is estimated to generate robust sales of diagnostic tests market in the next coming years. The diagnostic tests segment accounted for over 85% of market share during 2017 regionally.

The report profiles some of the leading players operating in the market. Some of these players are Becton, Dickinson and company., Micromedic Technologies Ltd., Quest Diagnostics, Inc, QIAGEN N.V., Hologic, Inc, OncoHealth Corporation, F. Hoffmann La-Roche Ltd., and Abbott Laboratories. According to the research study, the leading players in the market are focusing on expansion, and mergers and acquisitions to consolidate their position in the market.

Browse Full Global Cervical Dysplasia Market Report with TOC : https://www.mrrse.com/cervical-dysplasia-market

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559
Email: sales@mrrse.com